Home › Bio-Path Holdings Reports Third Quarter 2014 Operational and Financial Results
 

Keywords :   


Bio-Path Holdings Reports Third Quarter 2014 Operational and Financial Results

2014-11-18 11:35:59| Semiconductors - Topix.net

Bio-Path Holdings, Inc., , a biotechnology company developing a liposomal delivery technology for nucleic acid cancer drugs, today announced operational and financial results for the third quarter ended September 30, 2014. The final patient of cohort six completed treatment in the Phase I clinical trial evaluating Bio-Path's lead product candidate, BP-100-1.01 in blood cancers.

Tags: results reports financial quarter

Category:Electronics and Electrical

Latest from this category

All news
»
06.10Glatfelter Develops Biobased Espresso Lid Material
06.10Tropical Storm Milton Potential Storm Surge Flooding Map
06.10Tropical Storm Milton Probabilistic Storm Surge Graphics
06.10Firms urge mayor to rethink congestion charge plan
06.10Tropical Storm Milton Public Advisory Number 5
06.10Summary for Tropical Storm Milton (AT4/AL142024)
06.10Tropical Storm Milton Graphics
06.10Tropical Storm Milton Graphics
More »